India  

Pfizer Says Its Booster Provides Protection Against Omicron Variant

Video Credit: Wibbitz Top Stories - Duration: 01:30s - Published
Pfizer Says Its Booster Provides Protection Against Omicron Variant

Pfizer Says Its Booster Provides Protection Against Omicron Variant

Pfizer Says Its Booster Provides , Protection Against Omicron Variant.

Pfizer Says Its Booster Provides , Protection Against Omicron Variant.

NBC News reports officials with Pfizer-BioNTech say a booster dose of the companies' coronavirus vaccine supplies ample protection against the new Omicron variant.

NBC News reports officials with Pfizer-BioNTech say a booster dose of the companies' coronavirus vaccine supplies ample protection against the new Omicron variant.

Research shows their booster shot offers a similar degree of protection as two regular doses of their vaccine does against the original COVID-19 strain.

Three doses against Omicron are almost equivalent to the two doses effectiveness we had against the... original variant.

, Albert Bourla, CEO Pfizer, via NBC News.

Lab tests suggest two doses of the Pfizer-BioNTech vaccine experience a 25-fold drop in efficacy when matched against the Omicron strain.

An independent study showed the Pfizer vaccine's regular dose experienced a forty-fold reduction in neutralizing antibodies.

.

An independent study showed the Pfizer vaccine's regular dose experienced a forty-fold reduction in neutralizing antibodies.

.

Officials say these results are preliminary.

More data will be necessary.

Initially found in South Africa, the heavily-mutated Omicron variant is quickly spreading around the globe.

Initially found in South Africa, the heavily-mutated Omicron variant is quickly spreading around the globe.

Pfizer says it has begun work on an Omicron-specific vaccine.

According to officials it could be ready in around 100 days.

If we need a new vaccine, those tests are telling me we will be able to have a very good one if we need one.

, Albert Bourla, CEO Pfizer, via NBC News.

The current booster will maintain protection, but if we need one, we will make one and we will have it by March.

, Albert Bourla, CEO Pfizer, via NBC News .

The current booster will maintain protection, but if we need one, we will make one and we will have it by March.

, Albert Bourla, CEO Pfizer, via NBC News


You Might Like


💡 newsR Knowledge: Other News Mentions

Pfizer Pfizer American multinational pharmaceutical and biotechnology corporation

Pfizer Says Updated COVID-19 Shot Effective Against Omicron [Video]

Pfizer Says Updated COVID-19 Shot Effective Against Omicron

Pfizer Says Updated COVID-19 Shot , Effective Against Omicron. NBC News reports Pfizer announced on June 25 that its updated coronavirus vaccine better targets the omicron variant. Experts say while current vaccines offer ample protection against new variants, . their effectiveness has waned in the age of omicron. The Food and Drug Administration has considered ordering altered vaccines, . hoping a modified recipe could offer more protection when coronavirus surges again this fall and winter. Pfizer says after studying over 1,200 adults who had received three vaccine doses. officials say each of their vaccines showed a substantial increase in omicron-resistant antibodies. Based on these data, we believe we have two very strong omicron- adapted candidates. , statement from Pfizer CEO Albert Bourla, via NBC News. Pfizer's tweaked shot shows a 9 to 11-fold increase in omicron-fighting antibodies. almost 1.5 times higher than the company's initial dose

Credit: Wibbitz Top Stories    Duration: 01:30Published
FDA Panel Endorses COVID Vaccines for Children Under 5 [Video]

FDA Panel Endorses COVID Vaccines for Children Under 5

FDA Panel , Endorses COVID Vaccines, for Children Under 5. On June 15, an advisory panel to the United States Food and Drug Administration voted to recommend two COVID-19 vaccines for kids ages 5 and under. Yahoo reports that both Pfizer/BioNTech and Moderna were under review by the panel. . The unanimous FDA panel vote is the first step in what is predicted to be a quick authorization process. According to Yahoo, data from trials shows that both vaccines continue to protect against severe disease, hospitalization and death. According to Yahoo, data from trials shows that both vaccines continue to protect against severe disease, hospitalization and death. Yahoo reports that parents now have two options for how to vaccinate their children. Pfizer's vaccine for kids is delivered in three, three-microgram doses, while Moderna's vaccine is delivered in two shots of a 25-microgram dose. Our robust clinical study shows that three doses can provide protection for the circulating Omicron variant and offers promise for protection against potential future waves of COVID-19, Dr. Bill Gruber, Pfizer's Vaccine Clinical Research and Development head, via Yahoo. Our robust clinical study shows that three doses can provide protection for the circulating Omicron variant and offers promise for protection against potential future waves of COVID-19, Dr. Bill Gruber, Pfizer's Vaccine Clinical Research and Development head, via Yahoo. The committee’s support today is imperative to providing a critical tool for pediatricians, parents, and caregivers who eagerly await an option for children under five, Dr. Bill Gruber, Pfizer's Vaccine Clinical Research and Development head, via Yahoo. Both companies are now awaiting approval from the FDA and the CDC which will hold an advisory committee meeting on the topic over the weekend.

Credit: Wibbitz Top Stories    Duration: 01:30Published
Pfizer's COVID Vaccine for Kids Under 5 Moves Closer to FDA Approval [Video]

Pfizer's COVID Vaccine for Kids Under 5 Moves Closer to FDA Approval

Pfizer's COVID Vaccine for Kids Under 5 , Moves Closer to FDA Approval . Pfizer announced on June 1 that its application to the Food and Drug Administration (FDA) for the vaccine was complete. Pfizer announced on June 1 that its application to the Food and Drug Administration (FDA) for the vaccine was complete. The three-dose vaccine is for children between the ages of six months and five years. Pfizer released a statement detailing the application. Pfizer and BioNTech completed a rolling application to the U.S. Food and Drug Administration (FDA) for emergency use authorization (EUA)... , Pfizer Statement, via ABC News. ... of the 3-µg [microgram] dose of the Pfizer-BioNTech COVID-19 Vaccine.., Pfizer Statement, via ABC News. ... for children 6 months through 4 years of age (also referred to as 6 months to under 5 years of age) on June 1, 2022, Pfizer Statement, via ABC News. Pfizer reported an 80 percent effectiveness rate in children in May. The FDA also released a statement on June 1, confirming that the agency had accepted the Pfizer application. We recognize parents are anxious to have their young children vaccinated against COVID-19... , FDA Statement, via ABC News. ... and while the FDA cannot predict how long its evaluation of the data and information will take, , FDA Statement, via ABC News. ... we will review any EUA request we receive as quickly as possible using a science-based approach, FDA Statement, via ABC News. According to a poll conducted by the Kaiser Family Foundation in April of this year. ... just 18 percent of parents intend to have their children vaccinated once the vaccine is approved. 27 percent of parents stated that they will "definitely not" vaccinate their children against COVID

Credit: Wibbitz Top Stories    Duration: 01:31Published
Pfizer’s 3-Dose Vaccine 80% Effective Against Omicron Infection for Youngest Children [Video]

Pfizer’s 3-Dose Vaccine 80% Effective Against Omicron Infection for Youngest Children

Pfizer’s 3-Dose Vaccine , 80% Effective Against Omicron, Infection for Youngest Children. ABC News reports new data shows Pfizer's 3-dose vaccine is 80% effective against omicron infections in children five years old and younger. In all age groups, Pfizer's coronavirus vaccine has been less effective against mild breakthrough infections. but has been shown to offer high protection against severe disease and death. Experts say Pfizer's announcement offers reassurance to parents who wish to protect their children against coronavirus. We are pleased that our formulation for the youngest children, which we carefully selected to be one-tenth of the dose strength for adults ... , statement from Albert Bourla, chairman CEO Pfizer, via ABC News. ... was well tolerated and produced a strong immune response. , statement from Albert Bourla, chairman CEO Pfizer, via ABC News. After two years without a vaccine for young children, many pediatricians and parents intend to vaccinate as soon as possible. However, recent polls have shown over 50% of parents feel they need more information before their children receive a COVID-19 shot. Parents should also be aware that this preliminary data will be supplemented by additional data in June ... , Dr. Alok Patel, pediatric hospitalist Stanford Children's Health, via ABC News. ... which will then be thoroughly reviewed by both the FDA and the CDC. , Dr. Alok Patel, pediatric hospitalist Stanford Children's Health, via ABC News

Credit: Wibbitz Top Stories    Duration: 01:30Published
CDC Signs Off on COVID Vaccine Boosters for Kids Ages 5–11 [Video]

CDC Signs Off on COVID Vaccine Boosters for Kids Ages 5–11

CDC Signs Off on COVID Vaccine Boosters , for Kids Ages 5–11. CNN reports that on May 19, the CDC's Advisory Committee on Immunization Practices (ACIP)... . ... voted in support of recommending an additional Pfizer shot for 5- to 11-year-olds who've received their first two doses. The vote was 11-1 with 1 abstention. CNN reports that the FDA authorized the booster dose earlier this week. Children within this age group are advised to wait at least five months after receiving their two-dose regimen before getting a booster shot. CNN reports a fourth dose is recommended for children who are immunocompromised. . According to Pfizer, a trial of 4,500 children ages 5-11 showed Omicron-fighting antibodies were 36 times stronger upon receiving a booster. The company also says no new safety issues were detected. On May 16, the American Academy of Pediatrics reported that COVID cases in U.S. children rose 76% the previous week compared to two weeks prior. CDC Director Dr. Rochelle Walensky gave opening remarks before the ACIP's vote. The sadness I feel for lives lost, the families devastated and the communities changed is steep. We have the tools we need to protect these people from severe disease and prevent any more tragic deaths, Dr. Rochelle Walensky, via opening remarks before the ACIP's vote, via CNN

Credit: Wibbitz Top Stories    Duration: 01:31Published

BioNTech BioNTech German biotechnology company


SARS-CoV-2 Omicron variant SARS-CoV-2 Omicron variant November 2021 variant of SARS-CoV-2

Covid-19 update: 23 new cases of Omicron sub-variants BA.4, BA.5 in Maharashtra, total at 49

Among the 49 samples, 28 are located in Mumbai, 15 in Pune, 4 in Nagpur, and two in Thane.
DNA
Moderna Says New Booster Shows 'Superior' Omicron Response [Video]

Moderna Says New Booster Shows 'Superior' Omicron Response

Moderna Says New Booster , Shows 'Superior' Omicron Response. NPR reports Moderna claims its most recent vaccine candidate has shown a "superior neutralizing antibody response" when compared to its first vaccine. It is "bivalent," engineered to target two different antigens. Per NPR, Moderna intends to make its newest booster available in fall 2022. We are submitting our preliminary data and analysis to regulators with the hope that the Omicron-containing bivalent booster will be available in the late summer. , Stéphane Bancel, Moderna CEO, via statement. Due to a higher antibody response, Moderna believes its newest vaccine will offer protection that is "more durable over time" against Omicron. Due to a higher antibody response, Moderna believes its newest vaccine will offer protection that is "more durable over time" against Omicron. Moderna officials think their new vaccine could potentially offer protection for one year. As new variants continuously arise, Moderna officials hope the new bivalent vaccine can counter the more contagious strains taking hold in the United States. As new variants continuously arise, Moderna officials hope the new bivalent vaccine can counter the more contagious strains taking hold in the United States. According to the Centers for Disease Control and Prevention (CDC), two new subvariants of Omicron, BA.4 and BA.5, are spreading quickly across the country. Experts say another wave of coronavirus is bound to occur next winter as cold weather drives citizens back indoors

Credit: Wibbitz Top Stories    Duration: 01:30Published
India detects the cases of Omicron sub-variants BA.4 and BA.5, first detected in Tamil Nadu [Video]

India detects the cases of Omicron sub-variants BA.4 and BA.5, first detected in Tamil Nadu

The Indian SARS-CoV-2 Genomics Consortium (INSACOG) confirmed on Sunday that the first cases of Omicron's sub-variants BA.4 and BA.5 of the coronavirus have been detected in the country. the first case was reported in Tamil Nadu and the other cases have been detected in Telangana. #OmicronSubvariant #CasesInIndia #Live

Credit: Oneindia    Duration: 01:24Published
Covid-19 update: India logs 2,364 new cases and 10 deaths in last 24 hours | Oneindia News [Video]

Covid-19 update: India logs 2,364 new cases and 10 deaths in last 24 hours | Oneindia News

According to the Union Health ministry's data, India added 2,364 Covid cases and 10 Covid-related deaths in the last 24 hours. #CovidIndia #Covid19 #CovidCases #CoronaDeaths India, XE variant, Omicron, New Covid cases, Active cases, Daily new cases, Covid fatalities, Delta plus variant, Corona second wave, Corona third wave, Corona recovery rate, Weekly positivity rate, Covid tests done, Coronavirus case count, India, Covid vaccination drive, Omicron alert, Covid guidelines.

Credit: Oneindia    Duration: 01:06Published

South Africa South Africa Country in Southern Africa

England v South Africa: Natalie Sciver and Alice Davidson-Richards hit centuries to give England control

Watch highlights as Natalie Sciver and Alice Davidson-Richards score maiden centuries to put England in control after day two of the one-off Test against South..
BBC Sport

England v South Africa: Alice Davidson-Richards scores century on Test debut

Alice Davidson-Richards scores a century on her England Test debut on day two of the only Test against South Africa in Taunton.
BBC Sport

England v South Africa: Natalie Sciver scores maiden Test hundred

Natalie Sciver scores her maiden Test century from 182 balls as England gain control on day two of the only Test against South Africa in Taunton.
BBC Sport

England v South Africa: Heather Knight run out first ball after lunch

England captain Heather Knight is run out by Tumi Sekhukhune off the first ball after lunch on day two of the only Test in Taunton.
BBC Sport

England v South Africa: Anneke Bosch removes England openers

Anneke Bosch dismiss England openers Tammy Beaumont and Emma Lamb on day two of the only Test in Taunton.
BBC Sport

Related news from verified sources

Pfizer says Covid booster offers protection against omicron


Indian Express - Published


Related videos from verified sources

Experts Approach Omicron With Cautious Optimism [Video]

Experts Approach Omicron With Cautious Optimism

Experts Approach Omicron , With Cautious Optimism. Experts Approach Omicron , With Cautious Optimism. CNBC reports per the World Health Organization, the Omicron variant is now known to have caused..

Credit: Wibbitz Top Stories     Duration: 01:30Published
First Omicron Death Reported in the UK [Video]

First Omicron Death Reported in the UK

First Omicron Death , Reported in the UK. First Omicron Death , Reported in the UK. 'USA Today' reports the first known death attributed to the Omicron variant of COVID-19 has surfaced in the United..

Credit: Wibbitz Top Stories     Duration: 01:30Published
Booster provides up to 75% protection against Omicron [Video]

Booster provides up to 75% protection against Omicron

New data from the UK Health Security Agency (UKHSA) on the Omicron variant has shown the booster vaccine provides 70-75% effectiveness in protecting patients from symptomatic Covid. However, UKHSA..

Credit: ODN     Duration: 01:06Published